CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions

References

• Adams JC, Lawler J. 2011. The thrombospondins. Cold Spring Harb Perspect Biol. 3(10):a009712. doi: 10.1101/cshperspect.a009712
   PubMed Web of Science ®Google Scholar
• Avent N, Judson PA, Parsons SF, Mallinson G, Anstee DJ, Tanner MJ, Evans PR, Hodges E, Maciver AG, Holmes C. 1988. Monoclonal antibodies that recognize different membrane proteins that are deficient in Rhnull human erythrocytes. One group of antibodies reacts with a variety of cells and tissues whereas the other group is erythroid-specific. Biochem J. 251(2):499–505. doi: 10.1042/bj2510499
   PubMed Web of Science ®Google Scholar
• Barazi HO, Li Z, Cashel JA, Krutzsch HC, Annis DS, Mosher DF, Roberts DD. 2002. Regulation of integrin function by CD47 ligands. Differential effects on alpha vbeta 3 and alpha 4beta1 integrin-mediated adhesion. J Biol Chem. 277(45):42859–42866. doi: 10.1074/jbc.M206849200
   PubMed Web of Science ®Google Scholar
• Blazar BR, Lindberg FP, Ingulli E, Panoskaltsis-Mortari A, Oldenborg PA, Iizuka K, Yokoyama WM, Taylor PA. 2001. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med. 194(4):541–550. doi: 10.1084/jem.194.4.541
   PubMed Web of Science ®Google Scholar
• Bras M, Yuste VJ, Roue G, Barbier S, Sancho P, Virely C, Rubio M, Baudet S, Esquerda JE, Merle-Beral H, et al. 2007. Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Mol Cell Biol. 27(20):7073–7088. doi: 10.1128/MCB.02116-06
   PubMed Web of Science ®Google Scholar
• Brooke G, Holbrook JD, Brown MH, Barclay AN. 2004. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J Immunol. 173(4):2562–2570. doi: 10.4049/jimmunol.173.4.2562
   PubMed Web of Science ®Google Scholar
• Brown EJ, Frazier WA. 2001. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11(3):130–135. doi: 10.1016/S0962-8924(00)01906-1
   PubMed Web of Science ®Google Scholar
• Brown E, Hooper L, Ho T, Gresham H. 1990. Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol. 111(6 Pt 1):2785–2794. doi: 10.1083/jcb.111.6.2785
   PubMed Web of Science ®Google Scholar
• Campbell IG, Freemont PS, Foulkes W, Trowsdale J. 1992. An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res. 52(19):5416–5420.
   PubMed Web of Science ®Google Scholar
• Chao MP, Takimoto CH, Feng DD, McKenna K, Gip P, Liu J, Volkmer JP, Weissman IL, Majeti R. 2019. Therapeutic targeting of the macrophage immune checkpoint CD47 in myeloid malignancies. Front Oncol. 9:1380. doi: 10.3389/fonc.2019.01380
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, et al. 2009. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 16(8):1093–1107. doi: 10.1038/cdd.2009.44
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. 2018. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 25(3):486–541. doi: 10.1038/s41418-017-0012-4
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, et al. 2012. Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death Differ. 19(1):107–120. doi: 10.1038/cdd.2011.96
   PubMed Web of Science ®Google Scholar
• Gao AG, Frazier WA. 1994. Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins. J Biol Chem. 269(47):29650–29657.
   PubMed Web of Science ®Google Scholar
• Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. 1996. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem. 271(1):21–24. doi: 10.1074/jbc.271.1.21
   PubMed Web of Science ®Google Scholar
• Gresham HD, Goodwin JL, Allen PM, Anderson DC, Brown EJ. 1989. A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis. J Cell Biol. 108(5):1935–1943. doi: 10.1083/jcb.108.5.1935
   PubMed Web of Science ®Google Scholar
• Hatherley D, Graham SC, Turner J, Harlos K, Stuart DI, Barclay AN. 2008. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell. 31(2):266–277. doi: 10.1016/j.molcel.2008.05.026
   PubMed Web of Science ®Google Scholar
• Johansson U, Higginbottom K, Londei M. 2004. CD47 ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells. Scand J Immunol. 59(1):40–49. doi: 10.1111/j.0300-9475.2004.01355.x
   PubMed Web of Science ®Google Scholar
• Kalas W, Swiderek E, Rapak A, Kopij M, Rak J, Strzadala L. 2011. H-ras up-regulates expression of BNIP3. Anticancer Res. 31(9):2869–2875.
   PubMed Web of Science ®Google Scholar
• Kalas W, Swiderek E, Switalska M, Wietrzyk J, Rak J, Strzadala L. 2013. Thrombospondin-1 receptor mediates autophagy of RAS-expressing cancer cells and triggers tumour growth inhibition. Anticancer Res. 33(4):1429–1438.
   PubMed Web of Science ®Google Scholar
• Karki S, Nichols MR. 2014. CD47 does not mediate amyloid-beta(1-42) protofibril-stimulated microglial cytokine release. Biochem Biophys Res Commun. 454(1):239–244. doi: 10.1016/j.bbrc.2014.10.081
   PubMed Web of Science ®Google Scholar
• Khandelwal S, van Rooijen N, Saxena RK. 2007. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation. Transfusion. 47(9):1725–1732. doi: 10.1111/j.1537-2995.2007.01348.x
   PubMed Web of Science ®Google Scholar
• Kikuchi Y, Uno S, Kinoshita Y, Yoshimura Y, Iida S, Wakahara Y, Tsuchiya M, Yamada-Okabe H, Fukushima N. 2005. Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma. Leuk Res. 29(4):445–450. doi: 10.1016/j.leukres.2004.09.005
   PubMed Web of Science ®Google Scholar
• Kikuchi Y, Uno S, Yoshimura Y, Otabe K, Iida S, Oheda M, Fukushima N, Tsuchiya M. 2004. A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells. Biochem Biophys Res Commun. 315(4):912–918. doi: 10.1016/j.bbrc.2004.01.128
   PubMed Web of Science ®Google Scholar
• Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni W, Knight RA, et al. 2005. Classification of cell death: recommendations of the nomenclature committee on cell death. Cell Death Differ. 12(Suppl 2):1463–1467. doi: 10.1038/sj.cdd.4401724
   PubMedGoogle Scholar
• Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A. 2007. Interactions between CD47 and thrombospondin reduce inflammation. J Immunol. 178(9):5930–5939. doi: 10.4049/jimmunol.178.9.5930
   PubMed Web of Science ®Google Scholar
• Lamy L, Ticchioni M, Rouquette-Jazdanian AK, Samson M, Deckert M, Greenberg AH, Bernard A. 2003. CD47 and the 19kDa interacting protein-3 (BNIP3) in T cell apoptosis. J Biol Chem. 278(26):23915–23921. doi: 10.1074/jbc.M301869200
   PubMed Web of Science ®Google Scholar
• Leclair P, Kim MJ, Lim CJ. 2020. Peptide analogues PKHB1 and 4N1K induce cell death through CD47-independent mechanisms. Cancer Sci. 111(3):1028–1030. doi: 10.1111/cas.14310
   PubMed Web of Science ®Google Scholar
• Leclair P, Lim CJ. 2014. CD47-independent effects mediated by the TSP-derived 4N1K peptide. PLoS One. 9(5):e98358. doi: 10.1371/journal.pone.0098358
   PubMed Web of Science ®Google Scholar
• Leclair P, Liu CC, Monajemi M, Reid GS, Sly LM, Lim CJ. 2018. CD47-ligation induced cell death in T-acute lymphoblastic leukemia. Cell Death Dis. 9(5):544. doi: 10.1038/s41419-018-0601-2
   PubMedGoogle Scholar
• Lindberg FP, Gresham HD, Schwarz E, Brown EJ. 1993. Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J Cell Biol. 123(2):485–496. doi: 10.1083/jcb.123.2.485
   PubMed Web of Science ®Google Scholar
• Liu J, Wang L, Zhao F, Tseng S, Narayanan C, Shura L, Willingham S, Howard M, Prohaska S, Volkmer J, et al. 2015. Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential. PLoS One. 10(9):e0137345. doi: 10.1371/journal.pone.0137345
   PubMed Web of Science ®Google Scholar
• Logtenberg MEW, Jansen JHM, Raaben M, Toebes M, Franke K, Brandsma AM, Matlung HL, Fauster A, Gomez-Eerland R, Bakker NAM, et al. 2019. Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPalpha axis and a target for cancer immunotherapy. Nat Med. 25(4):612–619. doi: 10.1038/s41591-019-0356-z
   PubMed Web of Science ®Google Scholar
• Manna PP, Dimitry J, Oldenborg PA, Frazier WA. 2005. CD47 augments Fas/CD95-mediated apoptosis. J Biol Chem. 280(33):29637–29644. doi: 10.1074/jbc.M500922200
   PubMed Web of Science ®Google Scholar
• Manna PP, Frazier WA. 2003. The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A. J Immunol. 170(7):3544–3553. doi: 10.4049/jimmunol.170.7.3544
   PubMed Web of Science ®Google Scholar
• Manna PP, Frazier WA. 2004. CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A. Cancer Res. 64(3):1026–1036. doi: 10.1158/0008-5472.CAN-03-1708
   PubMed Web of Science ®Google Scholar
• Martinez-Torres AC, Calvillo-Rodriguez KM, Uscanga-Palomeque AC, Gomez-Morales L, Mendoza-Reveles R, Caballero-Hernandez D, Karoyan P, Rodriguez-Padilla C. 2019. PKHB1 tumor cell Lysate induces antitumor immune system stimulation and tumor regression in syngeneic mice with tumoral T lymphoblasts. J Oncol. 2019:9852361. doi: 10.1155/2019/9852361
   PubMed Web of Science ®Google Scholar
• Martinez-Torres AC, Quiney C, Attout T, Boullet H, Herbi L, Vela L, Barbier S, Chateau D, Chapiro E, Nguyen-Khac F, et al. 2015. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCgamma1 activation: evidence from mice and humans. PLoS Med. 12(3):e1001796. doi: 10.1371/journal.pmed.1001796
   PubMed Web of Science ®Google Scholar
• Mateo V, Brown EJ, Biron G, Rubio M, Fischer A, Deist FL, Sarfati M. 2002. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood. 100(8):2882–2890. doi: 10.1182/blood-2001-12-0217
   PubMed Web of Science ®Google Scholar
• Mateo V, Lagneaux L, Bron D, Biron G, Armant M, Delespesse G, Sarfati M. 1999. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat Med. 5(11):1277–1284. doi: 10.1038/15233
   PubMed Web of Science ®Google Scholar
• Mawby WJ, Holmes CH, Anstee DJ, Spring FA, Tanner MJ. 1994. Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem J. 304(Pt 2):525–530. doi: 10.1042/bj3040525
   PubMedGoogle Scholar
• Merle-Beral H, Barbier S, Roue G, Bras M, Sarfati M, Susin SA. 2009. Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia. Leukemia. 23(5):974–977. doi: 10.1038/leu.2008.321
   PubMed Web of Science ®Google Scholar
• Pagliuso A, Cossart P, Stavru F. 2018. The ever-growing complexity of the mitochondrial fission machinery. Cell Mol Life Sci. 75(3):355–374. doi: 10.1007/s00018-017-2603-0
   PubMed Web of Science ®Google Scholar
• Park GB, Bang SR, Lee HK, Kim D, Kim S, Kim JK, Kim YS, Hur DY. 2014. Ligation of CD47 induces G1 arrest in EBV-transformed B cells through ROS generation, p38 MAPK/JNK activation, and Tap73 upregulation. J Immunother. 37(6):309–320. doi: 10.1097/CJI.0000000000000042
   PubMed Web of Science ®Google Scholar
• Peluso MO, Adam A, Armet CM, Zhang L, O’Connor RW, Lee BH, Lake AC, Normant E, Chappel SC, Hill JA, et al. 2020. The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a. J Immunother Cancer. 8(1):e000413. doi: 10.1136/jitc-2019-000413
   PubMed Web of Science ®Google Scholar
• Petrova PS, Viller NN, Wong M, Pang X, Lin GH, Dodge K, Chai V, Chen H, Lee V, House V, et al. 2017. TTI-621 (SIRPalphaFc): a CD47-blocking innate immune checkpoint inhibitor with broad antitumor activity and minimal erythrocyte binding. Clin Cancer Res. 23(4):1068–1079. doi: 10.1158/1078-0432.CCR-16-1700
   PubMed Web of Science ®Google Scholar
• Pettersen RD, Hestdal K, Olafsen MK, Lie SO, Lindberg FP. 1999. CD47 signals T cell death. J Immunol. 162(12):7031–7040.
   PubMed Web of Science ®Google Scholar
• Piccione EC, Juarez S, Tseng S, Liu J, Stafford M, Narayanan C, Wang L, Weiskopf K, Majeti R. 2016. SIRPalpha-antibody fusion proteins selectively bind and eliminate dual antigen-expressing tumor cells. Clin Cancer Res. 22(20):5109–5119. doi: 10.1158/1078-0432.CCR-15-2503
   PubMed Web of Science ®Google Scholar
• Rebres RA, Vaz LE, Green JM, Brown EJ. 2001. Normal ligand binding and signaling by CD47 (integrin-associated protein) requires a long range disulfide bond between the extracellular and membrane-spanning domains. J Biol Chem. 276(37):34607–34616. doi: 10.1074/jbc.M106107200
   PubMed Web of Science ®Google Scholar
• Reinhold MI, Lindberg FP, Kersh GJ, Allen PM, Brown EJ. 1997. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med. 185(1):1–11. doi: 10.1084/jem.185.1.1
   PubMed Web of Science ®Google Scholar
• Reinhold MI, Lindberg FP, Plas D, Reynolds S, Peters MG, Brown EJ. 1995. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci. 108(Pt 11):3419–3425.
   PubMedGoogle Scholar
• Roue G, Bitton N, Yuste VJ, Montange T, Rubio M, Dessauge F, Delettre C, Merle-Beral H, Sarfati M, Susin SA. 2003. Mitochondrial dysfunction in CD47-mediated caspase-independent cell death: ROS production in the absence of cytochrome c and AIF release. Biochimie. 85(8):741–746. doi: 10.1016/S0300-9084(03)00129-9
   PubMed Web of Science ®Google Scholar
• Sagawa M, Shimizu T, Fukushima N, Kinoshita Y, Ohizumi I, Uno S, Kikuchi Y, Ikeda Y, Yamada-Okabe H, Kizaki M. 2011. A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1alpha pathway. Cancer Sci. 102(6):1208–1215. doi: 10.1111/j.1349-7006.2011.01925.x
   PubMed Web of Science ®Google Scholar
• Saumet A, Slimane MB, Lanotte M, Lawler J, Dubernard V. 2005. Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells. Blood. 106(2):658–667. doi: 10.1182/blood-2004-09-3585
   PubMed Web of Science ®Google Scholar
• Schwartz MA, Brown EJ, Fazeli B. 1993. A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J Biol Chem. 268(27):19931–19934.
   PubMed Web of Science ®Google Scholar
• Seiffert M, Cant C, Chen Z, Rappold I, Brugger W, Kanz L, Brown EJ, Ullrich A, Buhring HJ. 1999. Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood. 94(11):3633–3643. doi: 10.1182/blood.V94.11.3633
   PubMed Web of Science ®Google Scholar
• Soto-Pantoja DR, Kaur S, Roberts DD. 2015. CD47 signaling pathways controlling cellular differentiation and responses to stress. Crit Rev Biochem Mol Biol. 50(3):212–230. doi: 10.3109/10409238.2015.1014024
   PubMed Web of Science ®Google Scholar
• Ticchioni M, Deckert M, Mary F, Bernard G, Brown EJ, Bernard A. 1997. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J Immunol. 158(2):677–684.
   PubMed Web of Science ®Google Scholar
• Tsao PW, Mousa SA. 1995. Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains. J Biol Chem. 270(40):23747–23753. doi: 10.1074/jbc.270.40.23747
   PubMed Web of Science ®Google Scholar
• Tulasne D, Judd BA, Johansen M, Asazuma N, Best D, Brown EJ, Kahn M, Koretzky GA, Watson SP. 2001. C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor gamma-chain-associated signaling pathway and by agglutination. Blood. 98(12):3346–3352. doi: 10.1182/blood.V98.12.3346
   PubMed Web of Science ®Google Scholar
• Uno S, Kinoshita Y, Azuma Y, Tsunenari T, Yoshimura Y, Iida S, Kikuchi Y, Yamada-Okabe H, Fukushima N. 2007. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia. Oncol Rep. 17(5):1189–1194.
   PubMed Web of Science ®Google Scholar
• Uscanga-Palomeque AC, Calvillo-Rodriguez KM, Gomez-Morales L, Larde E, Denefle T, Caballero-Hernandez D, Merle-Beral H, Susin SA, Karoyan P, Martinez-Torres AC, et al. 2019. CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells. Cancer Sci. 110(1):256–268. doi: 10.1111/cas.13885
   PubMed Web of Science ®Google Scholar
• Waclavicek M, Majdic O, Stulnig T, Berger M, Baumruker T, Knapp W, Pickl WF. 1997. T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4. J Immunol. 159(11):5345–5354.
   PubMed Web of Science ®Google Scholar
• Wu Z, Weng L, Zhang T, Tian H, Fang L, Teng H, Zhang W, Gao J, Hao Y, Li Y, et al. 2019. Identification of glutaminyl cyclase isoenzyme isoQC as a regulator of SIRPalpha-CD47 axis. Cell Res. 29(6):502–505. doi: 10.1038/s41422-019-0177-0
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen W, Fan J, Wang S, Xian Z, Luan J, Li Y, Wang Y, Nan Y, Luo M, et al. 2018. Disrupting CD47-SIRPalpha axis alone or combined with autophagy depletion for the therapy of glioblastoma. Carcinogenesis. 39(5):689–699. doi: 10.1093/carcin/bgy041
   PubMed Web of Science ®Google Scholar
• Zhang X, Fan J, Wang S, Li Y, Wang Y, Li S, Luan J, Wang Z, Song P, Chen Q, et al. 2017. Targeting CD47 and autophagy elicited enhanced antitumor effects in non-small cell lung cancer. Cancer Immunol Res. 5(5):363–375. doi: 10.1158/2326-6066.CIR-16-0398
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu H, Xiang L, Bullen JW, Zhang C, Samanta D, Gilkes DM, He J, Semenza GL. 2015. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells. Proc Natl Acad Sci U S A. 112(45):E6215–E6223. doi: 10.1073/pnas.1520032112
   PubMed Web of Science ®Google Scholar
• Zhou M, Brown EJ. 1993. Leukocyte response integrin and integrin-associated protein act as a signal transduction unit in generation of a phagocyte respiratory burst. J Exp Med. 178(4):1165–1174. doi: 10.1084/jem.178.4.1165
   PubMed Web of Science ®Google Scholar